Angeloylartabsin

Details

Top
Internal ID 8b2fcc83-fadb-46e3-91de-776429bd8a1e
Taxonomy Lipids and lipid-like molecules > Fatty Acyls > Fatty acid esters
IUPAC Name [(3S,3aR,4S,6S,9bS)-6-hydroxy-3,6,9-trimethyl-2-oxo-3,3a,4,5,8,9b-hexahydroazuleno[4,5-b]furan-4-yl] (Z)-2-methylbut-2-enoate
SMILES (Canonical) CC=C(C)C(=O)OC1CC(C2=CCC(=C2C3C1C(C(=O)O3)C)C)(C)O
SMILES (Isomeric) C/C=C(/C)\C(=O)O[C@H]1C[C@](C2=CCC(=C2[C@@H]3[C@@H]1[C@@H](C(=O)O3)C)C)(C)O
InChI InChI=1S/C20H26O5/c1-6-10(2)18(21)24-14-9-20(5,23)13-8-7-11(3)15(13)17-16(14)12(4)19(22)25-17/h6,8,12,14,16-17,23H,7,9H2,1-5H3/b10-6-/t12-,14-,16+,17+,20-/m0/s1
InChI Key ASGYUBOOEJENCP-AURNDOKASA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C20H26O5
Molecular Weight 346.40 g/mol
Exact Mass 346.17802393 g/mol
Topological Polar Surface Area (TPSA) 72.80 Ų
XlogP 1.80
Atomic LogP (AlogP) 2.84
H-Bond Acceptor 5
H-Bond Donor 1
Rotatable Bonds 2

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Angeloylartabsin

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9820 98.20%
Caco-2 + 0.6892 68.92%
Blood Brain Barrier + 0.6500 65.00%
Human oral bioavailability - 0.6143 61.43%
Subcellular localzation Mitochondria 0.5919 59.19%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8928 89.28%
OATP1B3 inhibitior + 0.9257 92.57%
MATE1 inhibitior - 0.9000 90.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior + 0.7519 75.19%
P-glycoprotein inhibitior - 0.5875 58.75%
P-glycoprotein substrate - 0.6593 65.93%
CYP3A4 substrate + 0.6443 64.43%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.9129 91.29%
CYP3A4 inhibition - 0.7726 77.26%
CYP2C9 inhibition - 0.7955 79.55%
CYP2C19 inhibition - 0.8426 84.26%
CYP2D6 inhibition - 0.9564 95.64%
CYP1A2 inhibition - 0.5992 59.92%
CYP2C8 inhibition - 0.8114 81.14%
CYP inhibitory promiscuity - 0.9222 92.22%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9400 94.00%
Carcinogenicity (trinary) Non-required 0.4352 43.52%
Eye corrosion - 0.9767 97.67%
Eye irritation - 0.8240 82.40%
Skin irritation - 0.5388 53.88%
Skin corrosion - 0.9067 90.67%
Ames mutagenesis - 0.5000 50.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7463 74.63%
Micronuclear - 0.5800 58.00%
Hepatotoxicity + 0.7357 73.57%
skin sensitisation - 0.7563 75.63%
Respiratory toxicity + 0.6556 65.56%
Reproductive toxicity + 0.7667 76.67%
Mitochondrial toxicity + 0.8625 86.25%
Nephrotoxicity + 0.7388 73.88%
Acute Oral Toxicity (c) II 0.4516 45.16%
Estrogen receptor binding + 0.5966 59.66%
Androgen receptor binding + 0.5531 55.31%
Thyroid receptor binding + 0.6500 65.00%
Glucocorticoid receptor binding + 0.6292 62.92%
Aromatase binding - 0.6979 69.79%
PPAR gamma - 0.5101 51.01%
Honey bee toxicity - 0.6976 69.76%
Biodegradation - 0.8750 87.50%
Crustacea aquatic toxicity - 0.5500 55.00%
Fish aquatic toxicity + 0.9430 94.30%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.98% 91.11%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 92.85% 94.45%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 90.77% 95.56%
CHEMBL1293249 Q13887 Kruppel-like factor 5 89.55% 86.33%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 87.95% 99.23%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 85.53% 96.09%
CHEMBL1806 P11388 DNA topoisomerase II alpha 83.02% 89.00%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 80.14% 97.14%

Cross-Links

Top
PubChem 101078309
NPASS NPC224242
LOTUS LTS0099174
wikiData Q104917817